Richard Lindahl - EVP, Emergent Biosolutions Inc

As of March 2, 2022


What is Richard Lindahl's Net Worth?

The current estimated net worth of Emergent Biosolutions Inc's EVP, Richard Lindahl, is estimated to be about $1.01M . Richard Lindahl owns about 39,919 units of Emergent Biosolutions Inc common stock. In the last 4 years at Emergent Biosolutions Inc, Richard Lindahl has sold an estimated value of $873.57K worth.

What is Richard Lindahl's Past Insider Trading?

Richard Lindahl's largest purchase order was 3,000 units , worth over $112.38K on November 15, 2021. In total, Richard Lindahl has made about 12 transactions over 4 years of their time at Emergent Biosolutions Inc. Richard Lindahl usually trades in February, with the busiest year in 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Richard Lindahl's Salary in 2020?

As EVP of Emergent Biosolutions Inc, Richard Lindahl has a total base salary of $549,390 . Richard Lindahl received compensation valued at about $2,281,300 in 2020 after becoming EVP. The vast majority of their compensation came in the form of stock awards of $749,998 , option awards of $509,425 , other earnings, plans or compensations of $462,012 , and other compensation of $10,475 .

What is Richard Lindahl's' Mailing Address?

  • Mailing address is Nextel 2001 Edmund Halley Dr Reston VA 20191 VA

Emergent Biosolutions Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Fuad El-Hibri 2020 $1,192,202 $1,200,046 $815,051 - $6,185 $3,213,484
Fuad El-Hibri 2019 $1,131,577 $1,099,949 $773,813 - $4,723 $3,010,062
Fuad El-Hibri 2018 $1,047,031 $957,456 $957,481 - $8,250 $2,970,218
Robert Kramer 2020 $893,860 $2,050,007 $1,392,416 $1,225,020 $8,675 $5,569,978
Robert Kramer 2019 $678,021 $1,439,958 $1,012,999 $557,108 $5,735 $3,693,821
Robert Kramer 2018 $549,047 $649,930 $649,980 $538,807 $8,983 $2,396,747
Richard Lindahl 2020 $549,390 $749,998 $509,425 $462,012 $10,475 $2,281,300
Richard Lindahl 2019 $514,826 $619,984 $436,154 $297,429 $9,104 $1,877,497
Richard Lindahl 2018 $365,393 $557,438 $351,101 $330,007 $8,514 $1,612,453
Adam Havey 2020 $546,507 $700,047 $475,413 $445,204 $8,357 $2,175,528
Adam Havey 2019 $484,120 $619,984 $436,154 $279,579 $25,530 $1,845,367
Adam Havey 2018 $480,728 $499,974 $359,784 $310,212 $8,383 $1,659,081
Atul Saran 2020 $528,803 $700,047 $475,413 $445,204 $9,565 $2,159,032
Atul Saran 2019 $503,774 $619,984 $436,154 $293,567 $9,500 $1,862,979
Atul Saran 2018 $488,730 $527,475 $379,572 $293,567 $8,683 $1,698,027
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1367644/000136764421000061/ebsi2021asmproxystatement.htm

What are Emergent Biosolutions Inc's Past Insider Trades?

Emergent Biosolutions Inc's most recent insider trade came on June 13, 2022 by Kathryn Zoon who sold 1,173 units worth $36.97K . In the last 16 years, insiders at Emergent Biosolutions Inc have sold an estimated value of $238.06M and bought an estimated value of $38.64M worth of shares. Insider trading is most common in May, with the busiest year in 2007. The most active traders at the company are Fuad Elhibri, Director,  Daniel Abdunnabi, CEO,  and Robert Kramer, President and CEO .

Emergent BioSolutions Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1